Loading…
Held by 3 funds across 2 fund houses in our coverage.
Coverage: 23 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Gujarat Themis Biosyn is held by 3 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹53 Cr. Among all holding funds, the manager with the highest conviction is quant Manufacturing Fund (Quant MF), which allocates a significant 5.70% of its entire portfolio to Gujarat Themis Biosyn.
In terms of category distribution, Smart-Beta / Factor funds hold the largest exposure by market value, representing 1 positions. Across different fund houses, Quant MF manages the largest aggregate stake, holding a combined value of ₹53 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
| # | MoM | Rank | ||||
|---|---|---|---|---|---|---|
| 1 | quant Manufacturing FundQuant MFSmart-Beta / Factor₹42.05 CrIncreased+0.9% | 5.70% | Increased+0.9% | ₹42.05 Cr | 9.96 L | #9 of 14 |
| 2 | quant Value FundQuant MFValue₹10.89 Cr─ | 0.55% | ─ | ₹10.89 Cr | 2.58 L | #19 of 20 |
| 3 | Motilal Oswal S&P BSE Healthcare ETFMotilal Oswal MFEquity (Diversified)₹3.66 L | 0.08% | — | ₹3.66 L | 867 | #87 of 125 |
Portfolios as on: Quant MF Aug 2026 · Motilal Oswal MF Aug 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).